Choice of Valve Substitute in the Era of Oral Anticoagulation Self-Management
NCT01269905 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2011-01-04
Summary
The optimal valve substitute for patients between 60-70 years is controversial. We compared anticoagulation-related adverse events (ARAE) in patients receiving mechanical heart valve replacement (MHVR) on INR self-management vs. stentless bioprosthesis, to assess whether the risk of structural valve deterioration (SVD) is still out-weighted by the benefit of not requiring permanent anticoagulation.
Conditions
- Anticoagulation
- Mechanical Heart Valve Replacement
Sponsors & Collaborators
-
Johann Wolfgang Goethe University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Comparative Analysis of Stented Biological Prosthesis Versus Aortic Allograft in Patients With Degenerative Aortic Valve Disease
NCT07210541 ·Status: COMPLETED
-
Association Between Surgical Aortic Valve Replacement and Long-term Outcomes in 50 to 65-year-olds
NCT06782620 ·Status: COMPLETED
-
Observatory of Anticoagulation After Bioprosthetic Aortic Valve Replacement
NCT01293188 ·Status: COMPLETED
-
Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)
NCT04437303 ·Status: COMPLETED ·Phase: PHASE4
-
Screening for Amyloidosis Before Aortic Valve Elective Replacement
NCT04869631 ·Status: ACTIVE_NOT_RECRUITING
-
Randomized Study for the Optimal Treatment of Symptomatic Patients With Low Gradient Severe Aortic Valve Stenosis and Preserved Left Ventricular Ejection Fraction
NCT03667365 ·Status: TERMINATED ·Phase: NA
-
Patient International Normalised Ratio (INR) Self-Testing Program
NCT00925197 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Effects of Aortic Valve Mismatch
NCT00854698 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
NCT03112980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Long-term Prognosis and Valve Durability of TAVR
NCT06379386 ·Status: RECRUITING
-
Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation.
NCT04009434 ·Status: UNKNOWN ·Phase: NA
-
Incidence of Hemocompatibility Events With or Without Aspirin in Patients With CH-VAD
NCT07343102 ·Status: COMPLETED
-
accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
NCT03863132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.
NCT02128841 ·Status: TERMINATED ·Phase: PHASE2
-
Parasternal vs. Sternotomy Approach for Conventional Aortic Valve Replacement
NCT04632095 ·Status: UNKNOWN ·Phase: NA
-
Retrospective Observational Study of Patients With a Sutureless Aortic Valve Implanted in the Cardiovascular and Thoracic Surgery Department of Dijon CHU
NCT03259945 ·Status: COMPLETED
-
Early Versus Deferred Aortic Valve Replacement in Patients With Moderate Aortic Stenosis and Mitral Regurgitation
NCT05310461 ·Status: RECRUITING ·Phase: NA
-
Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement
NCT05261204 ·Status: ENROLLING_BY_INVITATION
-
Assessment of Arrhythmias in Patients Undergoing Transcatheter Aortic Valve Implantation Using a Small Insertable Cardiac Monitoring Device
NCT02559011 ·Status: COMPLETED
-
Bioprothetic Valve Versus Mechanical Valve of Bioprothetic Valve Versus Mechanical Valve
NCT06041308 ·Status: RECRUITING
-
Long-Term Follow-up After the Autograft Aortic Valve Procedure (Ross Operation)
NCT00708409 ·Status: UNKNOWN
-
Children and Adolescents Receiving Mechanical and Prosthetic Valves
NCT00268008 ·Status: TERMINATED
-
Feasibility of Valve-in-Root Transcatheter Aortic Valve Implantation in 363 Patients After Aortic Root Replacement and Repair
NCT06697249 ·Status: COMPLETED
-
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
NCT01531374 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves
NCT06476301 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4